Learn how targeted therapy and molecular profiling are advancing personalized cancer treatment. Understand how genetic insights guide therapy decisions to improve outcomes.
HER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
FCS Top News Updates
FCS Signals Next Chapter of Growth With Planned Leadership Transition and Focus on Innovation
Get the facts about grains and their impact on your health. Discover if eating grains can contribute to a healthy lifestyle or if they should be avoided.
You may have heard the terms Mindful Eating or Intuitive Eating floating around in the news or social media. What do these terms mean? Will these practices help you meet your healthy eating goals?
FCS Physicians Driving Progress in Cancer ImmunotherapyFlorida Cancer Specialists & Research Institute abstracts presented at the Society for Immunotherapy of Cancer (SITC) 2025 annual meeting.
FCS Expands Team of Cancer Experts in TampaFlorida Cancer Specialists & Research Institute welcomes Yasir Alsaraf, MD to the FCS Tampa Cancer Center.
Targeted Therapy and Molecular Profiling in Cancer CareLearn how targeted therapy and molecular profiling are advancing personalized cancer treatment. Understand how genetic insights guide therapy decisions to improve outcomes.
Rx To Go Achieves Accreditation with ACHCRx To Go achieves ACHC re-accreditation for pharmacy with distinction in oncology.
Therapeutic PhlebotomySome conditions cause your body to overproduce red blood cells or iron. A phlebotomy will remove some of these cells.
Triple Negative Breast Cancer -Summary, Symptoms, TreatmentsTriple-negative breast cancer lacks three common receptors found in many other breast cancers: estrogen, progesterone, and HER2 protein. Learn more.
Bone Marrow BiopsyBone marrow biopsy and bone marrow aspiration are procedures to collect and examine bone marrow. Learn More.
HER2-Positive Breast Cancer – Summary, Symptoms, TreatmentsHER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
